Filtered By:
Infectious Disease: SARS
Drug: Enbrel

This page shows you your search results in order of date.

Order by Relevance | Date

Total 5 results found since Jan 2013.

Rapid improvement in severe long COVID following perispinal etanercept
CONCLUSION: Perispinal etanercept is a promising treatment for the chronic neurologic dysfunction that may persist after resolution of acute COVID-19, including chronic cognitive dysfunction, fatigue, and depression. These results suggest that long COVID brain neuroinflammation is a potentially reversible pathology and viable treatment target. In view of the increasing unmet medical need, clinical trials of perispinal etanercept for long COVID are urgently necessary. The robust results of the present case suggest that perispinal etanercept clinical trials studying long COVID populations with severe fatigue, depression and ...
Source: Current Medical Research and Opinion - July 6, 2022 Category: Research Authors: Edward Tobinick Robert N Spengler Tracey A Ignatowski Manar Wassel Samantha Laborde Source Type: research